Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
Universidade Federal de São Paulo
São Paulo, BrasilPublicaciones en colaboración con investigadores/as de Universidade Federal de São Paulo (7)
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2020
-
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients with Osteosarcoma
JAMA Oncology, Vol. 6, Núm. 5, pp. 724-734
2018
-
Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients
International Journal of Cancer, Vol. 142, Núm. 8, pp. 1594-1601
2017
-
Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trial
British Journal of Haematology, Vol. 179, Núm. 1, pp. 66-74
2015
-
A genome-wide scan identifies variants in NFIB associated with metastasis in patients with osteosarcoma
Cancer Discovery, Vol. 5, Núm. 9, pp. 920-931
-
Panobinostat: A novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma
Expert Review of Anticancer Therapy, Vol. 15, Núm. 7, pp. 737-748
2013
-
Genome-wide association study identifies two susceptibility loci for osteosarcoma
Nature Genetics, Vol. 45, Núm. 7, pp. 799-803